One-year Mortality of Cancer Patients with an Unplanned ICU Admission: A Cohort Analysis Between 2008 and 2017 in the Netherlands ...

Introduction: A decrease in short-term mortality of critically ill cancer patients with an unplanned intensive care unit (ICU) admission has been described. Few studies describe a change over time of 1-year mortality. Therefore, we examined the 1-year mortality of cancer patients (hematological or solid) with an unplanned ICU admission and we described whether the mortality changed over time. Methods: We used the National Intensive Care Evaluation (NICE) registry and extracted all patients with an unplanned ICU admission in the Netherlands between 2008 and 2017. The primary outcome was 1-year... Mehr ...

Verfasser: van der Zee, Esther N.
Termorshuizen, Fabian
Benoit, Dominique D.
de Keizer, Nicolette F.
Bakker, Jan
Kompanje, Erwin J.O.
Rietdijk, Wim J.R.
Epker, Jelle L.
Dokumenttyp: Datenquelle
Erscheinungsdatum: 2021
Verlag/Hrsg.: SAGE Journals
Schlagwörter: 110305 Emergency Medicine / FOS: Clinical medicine / 111702 Aged Health Care / FOS: Health sciences / 110203 Respiratory Diseases
Sprache: unknown
Permalink: https://search.fid-benelux.de/Record/base-29160801
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://dx.doi.org/10.25384/sage.c.5713217

Introduction: A decrease in short-term mortality of critically ill cancer patients with an unplanned intensive care unit (ICU) admission has been described. Few studies describe a change over time of 1-year mortality. Therefore, we examined the 1-year mortality of cancer patients (hematological or solid) with an unplanned ICU admission and we described whether the mortality changed over time. Methods: We used the National Intensive Care Evaluation (NICE) registry and extracted all patients with an unplanned ICU admission in the Netherlands between 2008 and 2017. The primary outcome was 1-year mortality, analyzed with a mixed-effects Cox proportional hazard regression. We compared the 1-year mortality of cancer patients to that of patients without cancer. Furthermore, we examined changes in mortality over the study period. Results: We included 470,305 patients: 10,401 with hematological cancer, 35,920 with solid cancer, and 423,984 without cancer. The 1-year mortality rates were 60.1%, 46.2%, and 28.3% ...